SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-019500
Filing Date
2023-05-30
Accepted
2023-05-30 17:29:39
Documents
14
Period of Report
2023-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45609
2 ex10-1.htm EX-10.1 123362
3 ex99-1.htm EX-99.1 19679
  Complete submission text file 0001493152-23-019500.txt   401599

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ghsi-20230527.xsd EX-101.SCH 3245
5 XBRL LABEL FILE ghsi-20230527_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ghsi-20230527_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3728
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 23977991
SIC: 2834 Pharmaceutical Preparations